Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P. Rovers, Aeilko H. Zwinderman, Checca Bakkers et al.|BMC Cancer|2019Cited by 111
Hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma confined to the liver: A multicenter phase II trial.Stijn Franssen, Bas Groot Koerkamp, Merve Rousian et al.|Journal of Clinical Oncology|2024Cited by 12
Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 TrialStijn Franssen, Bas Groot Koerkamp, Merve Rousian et al.|Journal of Clinical Oncology|2025Cited by 5
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi studyD. Kamp, Nadia Haj Mohammad|European Journal of Cancer|2025Cited by 1
Patient preference trials in oncology: a scoping review and recommendations on reportingD. Kamp, Rolf H. H. Groenwold, Roy P. C. Kessels et al.|Journal of Clinical Epidemiology|2025Cited by 1